VKTX – Viking Therapeutics, Inc.
Viking Therapeutics, Inc.VKTX
$27.00Name : Viking Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $3,032,920,320.00
EPSttm : -1.16
Viking Therapeutics, Inc.
$27.00
1.83%$0.4849Float Short %
26.13
Margin Of Safety %
Put/Call OI Ratio
0.24
EPS Next Q Diff
-0.07
EPS Last/This Y
-0.83
EPS This/Next Y
-0.64
Price
26.51
Target Price
90.26
Analyst Recom
1.21
Performance Q
1.49
Relative Volume
1.65
Beta
0.64
Ticker: VKTX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | VKTX | 26.23 | 0.29 | 0.22 | 170881 |
| 2025-06-03 | VKTX | 26.62 | 0.29 | 0.19 | 175609 |
| 2025-06-04 | VKTX | 27.01 | 0.29 | 0.11 | 177923 |
| 2025-06-05 | VKTX | 27.04 | 0.29 | 0.16 | 180536 |
| 2025-06-06 | VKTX | 27.83 | 0.29 | 0.19 | 182027 |
| 2025-06-09 | VKTX | 27.57 | 0.29 | 0.10 | 174374 |
| 2025-06-10 | VKTX | 29.15 | 0.28 | 0.09 | 186389 |
| 2025-06-11 | VKTX | 28.96 | 0.25 | 0.07 | 207334 |
| 2025-06-12 | VKTX | 28.58 | 0.25 | 0.10 | 217791 |
| 2025-06-13 | VKTX | 26.15 | 0.24 | 0.23 | 222962 |
| 2025-06-16 | VKTX | 26.95 | 0.25 | 0.15 | 222247 |
| 2025-06-17 | VKTX | 26.47 | 0.25 | 0.12 | 224971 |
| 2025-06-18 | VKTX | 26.27 | 0.25 | 0.13 | 226440 |
| 2025-06-20 | VKTX | 25.99 | 0.25 | 0.19 | 225583 |
| 2025-06-23 | VKTX | 24.86 | 0.25 | 0.55 | 188062 |
| 2025-06-24 | VKTX | 26.91 | 0.26 | 0.09 | 197518 |
| 2025-06-25 | VKTX | 27.08 | 0.25 | 0.11 | 211330 |
| 2025-06-26 | VKTX | 28.18 | 0.24 | 0.20 | 218955 |
| 2025-06-27 | VKTX | 26.54 | 0.24 | 0.19 | 226823 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | VKTX | 26.10 | -120.3 | -51.2 | -1.84 |
| 2025-06-03 | VKTX | 26.61 | -120.3 | -65.6 | -1.84 |
| 2025-06-04 | VKTX | 27.01 | -120.3 | -64.4 | -1.84 |
| 2025-06-05 | VKTX | 27.04 | -120.3 | -60.0 | -1.84 |
| 2025-06-06 | VKTX | 27.81 | -120.3 | -68.6 | -1.84 |
| 2025-06-09 | VKTX | 27.57 | -120.3 | -56.5 | -1.84 |
| 2025-06-10 | VKTX | 29.14 | -120.3 | -77.7 | -1.84 |
| 2025-06-11 | VKTX | 28.95 | -120.3 | -57.5 | -1.84 |
| 2025-06-12 | VKTX | 28.58 | -120.3 | -55.5 | -1.84 |
| 2025-06-13 | VKTX | 26.08 | -120.3 | -31.9 | -1.84 |
| 2025-06-16 | VKTX | 26.93 | -120.3 | -70.2 | -1.84 |
| 2025-06-17 | VKTX | 26.43 | -120.3 | -53.1 | -1.84 |
| 2025-06-18 | VKTX | 26.28 | -120.3 | -57.7 | -1.84 |
| 2025-06-20 | VKTX | 26.01 | -120.3 | -56.2 | -1.84 |
| 2025-06-23 | VKTX | 24.87 | -120.3 | -45.2 | -1.84 |
| 2025-06-24 | VKTX | 26.94 | -120.3 | -87.5 | -1.84 |
| 2025-06-25 | VKTX | 27.07 | -120.3 | -60.9 | -1.84 |
| 2025-06-26 | VKTX | 28.17 | -120.3 | -72.6 | -1.84 |
| 2025-06-27 | VKTX | 26.51 | -120.3 | -40.8 | -1.84 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | VKTX | -8.22 | -5.08 | 23.44 |
| 2025-06-03 | VKTX | -8.22 | -5.08 | 23.44 |
| 2025-06-04 | VKTX | -8.22 | -5.08 | 23.44 |
| 2025-06-05 | VKTX | -8.22 | -5.08 | 23.44 |
| 2025-06-06 | VKTX | -8.22 | -5.08 | 23.44 |
| 2025-06-09 | VKTX | -8.22 | -5.06 | 23.44 |
| 2025-06-10 | VKTX | -8.22 | -5.06 | 23.44 |
| 2025-06-11 | VKTX | -8.22 | -5.06 | 24.51 |
| 2025-06-12 | VKTX | -8.22 | -5.06 | 24.51 |
| 2025-06-13 | VKTX | -8.22 | -5.06 | 24.51 |
| 2025-06-16 | VKTX | -8.22 | -5.23 | 24.51 |
| 2025-06-18 | VKTX | -8.22 | -5.23 | 24.51 |
| 2025-06-20 | VKTX | -8.22 | -5.23 | 24.51 |
| 2025-06-23 | VKTX | -8.22 | -5.25 | 24.51 |
| 2025-06-24 | VKTX | -8.22 | -5.25 | 24.51 |
| 2025-06-25 | VKTX | -8.22 | -5.25 | 24.51 |
| 2025-06-26 | VKTX | -8.22 | -5.25 | 26.13 |
| 2025-06-27 | VKTX | -8.22 | -5.25 | 26.13 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.41
Avg. EPS Est. Current Quarter
-0.44
Avg. EPS Est. Next Quarter
-0.48
Insider Transactions
-8.22
Institutional Transactions
-5.25
Beta
0.64
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
14
Growth Score
25
Sentiment Score
82
Actual DrawDown %
73.3
Max Drawdown 5-Year %
-78.9
Target Price
90.26
P/E
Forward P/E
PEG
P/S
P/B
3.52
P/Free Cash Flow
EPS
-1.15
Average EPS Est. Cur. Y
-1.84
EPS Next Y. (Est.)
-2.49
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.65
Return on Equity vs Sector %
-39
Return on Equity vs Industry %
-21.2
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
-40.8
Viking Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 45
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
stock quote shares VKTX – Viking Therapeutics, Inc. Stock Price stock today
news today VKTX – Viking Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VKTX – Viking Therapeutics, Inc. yahoo finance google finance
stock history VKTX – Viking Therapeutics, Inc. invest stock market
stock prices VKTX premarket after hours
ticker VKTX fair value insiders trading